学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTIONS
被引:57
作者
:
HIRSCH, MS
论文数:
0
引用数:
0
h-index:
0
HIRSCH, MS
KAPLAN, JC
论文数:
0
引用数:
0
h-index:
0
KAPLAN, JC
机构
:
来源
:
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
|
1987年
/ 31卷
/ 06期
关键词
:
D O I
:
10.1128/AAC.31.6.839
中图分类号
:
Q93 [微生物学];
学科分类号
:
071005 ;
100705 ;
摘要
:
引用
收藏
页码:839 / 843
页数:5
相关论文
共 27 条
[1]
BOTH 2',3'-DIDEOXYTHYMIDINE AND ITS 2',3'-UNSATURATED DERIVATIVE (2',3'-DI-DEOXYTHYMIDINENE) ARE POTENT AND SELECTIVE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-REPLICATION INVITRO
BABA, M
论文数:
0
引用数:
0
h-index:
0
BABA, M
PAUWELS, R
论文数:
0
引用数:
0
h-index:
0
PAUWELS, R
HERDEWIJN, P
论文数:
0
引用数:
0
h-index:
0
HERDEWIJN, P
DECLERCQ, E
论文数:
0
引用数:
0
h-index:
0
DECLERCQ, E
DESMYTER, J
论文数:
0
引用数:
0
h-index:
0
DESMYTER, J
VANDEPUTTE, M
论文数:
0
引用数:
0
h-index:
0
VANDEPUTTE, M
[J].
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,
1987,
142
(01)
: 128
-
134
[2]
COMPARATIVE INHIBITORY EFFECTS OF SURAMIN AND OTHER SELECTED COMPOUNDS ON THE INFECTIVITY AND REPLICATION OF HUMAN T-CELL LYMPHOTROPIC VIRUS (HTLV-III) LYMPHADENOPATHY-ASSOCIATED VIRUS (LAV)
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
BALZARINI, J
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
MITSUYA, H
DECLERCQ, E
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
DECLERCQ, E
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
BRODER, S
[J].
INTERNATIONAL JOURNAL OF CANCER,
1986,
37
(03)
: 451
-
457
[3]
POTENT AND SELECTIVE ANTI-HTLV-III/LAV ACTIVITY OF 2',3'-DIDEOXYCYTIDINENE, THE 2',3'-UNSATURATED DERIVATIVE OF 2',3'-DIDEOXYCYTIDINE
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BALZARINI, J
PAUWELS, R
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
PAUWELS, R
HERDEWIJN, P
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
HERDEWIJN, P
DECLERCQ, E
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
DECLERCQ, E
COONEY, DA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
COONEY, DA
KANG, GJ
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
KANG, GJ
DALAL, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
DALAL, M
JOHNS, DG
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
JOHNS, DG
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BRODER, S
[J].
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,
1986,
140
(02)
: 735
-
742
[4]
BRODER S, 1985, LANCET, V2, P627
[5]
INITIAL STUDIES ON THE CELLULAR PHARMACOLOGY OF 2',3'-DIDEOXYCYTIDINE, AN INHIBITOR OF HTLV-III INFECTIVITY
COONEY, DA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
COONEY, DA
DALAL, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
DALAL, M
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
MITSUYA, H
MCMAHON, JB
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
MCMAHON, JB
NADKARNI, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NADKARNI, M
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BALZARINI, J
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BRODER, S
JOHNS, DG
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
JOHNS, DG
[J].
BIOCHEMICAL PHARMACOLOGY,
1986,
35
(13)
: 2065
-
2068
[6]
DORMONT D, 1985, ANN INST PASTEUR VIR, V136, P75, DOI 10.1016/S0769-2617(85)80114-3
[7]
PHOSPHORYLATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE AND SELECTIVE INTERACTION OF THE 5'-TRIPHOSPHATE WITH HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
FURMAN, PA
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
FURMAN, PA
FYFE, JA
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
FYFE, JA
STCLAIR, MH
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
STCLAIR, MH
WEINHOLD, K
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
WEINHOLD, K
RIDEOUT, JL
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
RIDEOUT, JL
FREEMAN, GA
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
FREEMAN, GA
LEHRMAN, SN
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
LEHRMAN, SN
BOLOGNESI, DP
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
BOLOGNESI, DP
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
BRODER, S
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
MITSUYA, H
BARRY, DW
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
BARRY, DW
[J].
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,
1986,
83
(21)
: 8333
-
8337
[8]
BIOCHEMISTRY AND CLINICAL-APPLICATIONS OF RIBAVIRIN
GILBERT, BE
论文数:
0
引用数:
0
h-index:
0
GILBERT, BE
KNIGHT, V
论文数:
0
引用数:
0
h-index:
0
KNIGHT, V
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1986,
30
(02)
: 201
-
205
[9]
INVITRO MODIFICATION OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTION BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND GAMMA-INTERFERON
HAMMER, SM
论文数:
0
引用数:
0
h-index:
0
机构:
HARVARD UNIV,SCH MED,BOSTON,MA 02115
HARVARD UNIV,SCH MED,BOSTON,MA 02115
HAMMER, SM
GILLIS, JM
论文数:
0
引用数:
0
h-index:
0
机构:
HARVARD UNIV,SCH MED,BOSTON,MA 02115
HARVARD UNIV,SCH MED,BOSTON,MA 02115
GILLIS, JM
GROOPMAN, JE
论文数:
0
引用数:
0
h-index:
0
机构:
HARVARD UNIV,SCH MED,BOSTON,MA 02115
HARVARD UNIV,SCH MED,BOSTON,MA 02115
GROOPMAN, JE
ROSE, RM
论文数:
0
引用数:
0
h-index:
0
机构:
HARVARD UNIV,SCH MED,BOSTON,MA 02115
HARVARD UNIV,SCH MED,BOSTON,MA 02115
ROSE, RM
[J].
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,
1986,
83
(22)
: 8734
-
8738
[10]
SYNERGISTIC INHIBITION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III REPLICATION INVITRO BY PHOSPHONOFORMATE AND RECOMBINANT ALPHA-A-INTERFERON
HARTSHORN, KL
论文数:
0
引用数:
0
h-index:
0
机构:
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
HARTSHORN, KL
SANDSTROM, EG
论文数:
0
引用数:
0
h-index:
0
机构:
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
SANDSTROM, EG
NEUMEYER, D
论文数:
0
引用数:
0
h-index:
0
机构:
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
NEUMEYER, D
PARADIS, TJ
论文数:
0
引用数:
0
h-index:
0
机构:
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
PARADIS, TJ
CHOU, TC
论文数:
0
引用数:
0
h-index:
0
机构:
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
CHOU, TC
SCHOOLEY, RT
论文数:
0
引用数:
0
h-index:
0
机构:
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
SCHOOLEY, RT
HIRSCH, MS
论文数:
0
引用数:
0
h-index:
0
机构:
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
HIRSCH, MS
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1986,
30
(01)
: 189
-
191
←
1
2
3
→
共 27 条
[1]
BOTH 2',3'-DIDEOXYTHYMIDINE AND ITS 2',3'-UNSATURATED DERIVATIVE (2',3'-DI-DEOXYTHYMIDINENE) ARE POTENT AND SELECTIVE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-REPLICATION INVITRO
BABA, M
论文数:
0
引用数:
0
h-index:
0
BABA, M
PAUWELS, R
论文数:
0
引用数:
0
h-index:
0
PAUWELS, R
HERDEWIJN, P
论文数:
0
引用数:
0
h-index:
0
HERDEWIJN, P
DECLERCQ, E
论文数:
0
引用数:
0
h-index:
0
DECLERCQ, E
DESMYTER, J
论文数:
0
引用数:
0
h-index:
0
DESMYTER, J
VANDEPUTTE, M
论文数:
0
引用数:
0
h-index:
0
VANDEPUTTE, M
[J].
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,
1987,
142
(01)
: 128
-
134
[2]
COMPARATIVE INHIBITORY EFFECTS OF SURAMIN AND OTHER SELECTED COMPOUNDS ON THE INFECTIVITY AND REPLICATION OF HUMAN T-CELL LYMPHOTROPIC VIRUS (HTLV-III) LYMPHADENOPATHY-ASSOCIATED VIRUS (LAV)
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
BALZARINI, J
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
MITSUYA, H
DECLERCQ, E
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
DECLERCQ, E
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
NCI, CLIN ONCOL PROGRAM, BETHESDA, MD 20205 USA
BRODER, S
[J].
INTERNATIONAL JOURNAL OF CANCER,
1986,
37
(03)
: 451
-
457
[3]
POTENT AND SELECTIVE ANTI-HTLV-III/LAV ACTIVITY OF 2',3'-DIDEOXYCYTIDINENE, THE 2',3'-UNSATURATED DERIVATIVE OF 2',3'-DIDEOXYCYTIDINE
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BALZARINI, J
PAUWELS, R
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
PAUWELS, R
HERDEWIJN, P
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
HERDEWIJN, P
DECLERCQ, E
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
DECLERCQ, E
COONEY, DA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
COONEY, DA
KANG, GJ
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
KANG, GJ
DALAL, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
DALAL, M
JOHNS, DG
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
JOHNS, DG
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BRODER, S
[J].
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,
1986,
140
(02)
: 735
-
742
[4]
BRODER S, 1985, LANCET, V2, P627
[5]
INITIAL STUDIES ON THE CELLULAR PHARMACOLOGY OF 2',3'-DIDEOXYCYTIDINE, AN INHIBITOR OF HTLV-III INFECTIVITY
COONEY, DA
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
COONEY, DA
DALAL, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
DALAL, M
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
MITSUYA, H
MCMAHON, JB
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
MCMAHON, JB
NADKARNI, M
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NADKARNI, M
BALZARINI, J
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BALZARINI, J
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
BRODER, S
JOHNS, DG
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
NCI,DIV CANC TREATMENT,CLIN ONCOL PROGRAM,BETHESDA,MD 20892
JOHNS, DG
[J].
BIOCHEMICAL PHARMACOLOGY,
1986,
35
(13)
: 2065
-
2068
[6]
DORMONT D, 1985, ANN INST PASTEUR VIR, V136, P75, DOI 10.1016/S0769-2617(85)80114-3
[7]
PHOSPHORYLATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE AND SELECTIVE INTERACTION OF THE 5'-TRIPHOSPHATE WITH HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE
FURMAN, PA
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
FURMAN, PA
FYFE, JA
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
FYFE, JA
STCLAIR, MH
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
STCLAIR, MH
WEINHOLD, K
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
WEINHOLD, K
RIDEOUT, JL
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
RIDEOUT, JL
FREEMAN, GA
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
FREEMAN, GA
LEHRMAN, SN
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
LEHRMAN, SN
BOLOGNESI, DP
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
BOLOGNESI, DP
BRODER, S
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
BRODER, S
MITSUYA, H
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
MITSUYA, H
BARRY, DW
论文数:
0
引用数:
0
h-index:
0
机构:
WELLCOME RES LABS, DEPT EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA
BARRY, DW
[J].
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,
1986,
83
(21)
: 8333
-
8337
[8]
BIOCHEMISTRY AND CLINICAL-APPLICATIONS OF RIBAVIRIN
GILBERT, BE
论文数:
0
引用数:
0
h-index:
0
GILBERT, BE
KNIGHT, V
论文数:
0
引用数:
0
h-index:
0
KNIGHT, V
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1986,
30
(02)
: 201
-
205
[9]
INVITRO MODIFICATION OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTION BY GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND GAMMA-INTERFERON
HAMMER, SM
论文数:
0
引用数:
0
h-index:
0
机构:
HARVARD UNIV,SCH MED,BOSTON,MA 02115
HARVARD UNIV,SCH MED,BOSTON,MA 02115
HAMMER, SM
GILLIS, JM
论文数:
0
引用数:
0
h-index:
0
机构:
HARVARD UNIV,SCH MED,BOSTON,MA 02115
HARVARD UNIV,SCH MED,BOSTON,MA 02115
GILLIS, JM
GROOPMAN, JE
论文数:
0
引用数:
0
h-index:
0
机构:
HARVARD UNIV,SCH MED,BOSTON,MA 02115
HARVARD UNIV,SCH MED,BOSTON,MA 02115
GROOPMAN, JE
ROSE, RM
论文数:
0
引用数:
0
h-index:
0
机构:
HARVARD UNIV,SCH MED,BOSTON,MA 02115
HARVARD UNIV,SCH MED,BOSTON,MA 02115
ROSE, RM
[J].
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,
1986,
83
(22)
: 8734
-
8738
[10]
SYNERGISTIC INHIBITION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III REPLICATION INVITRO BY PHOSPHONOFORMATE AND RECOMBINANT ALPHA-A-INTERFERON
HARTSHORN, KL
论文数:
0
引用数:
0
h-index:
0
机构:
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
HARTSHORN, KL
SANDSTROM, EG
论文数:
0
引用数:
0
h-index:
0
机构:
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
SANDSTROM, EG
NEUMEYER, D
论文数:
0
引用数:
0
h-index:
0
机构:
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
NEUMEYER, D
PARADIS, TJ
论文数:
0
引用数:
0
h-index:
0
机构:
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
PARADIS, TJ
CHOU, TC
论文数:
0
引用数:
0
h-index:
0
机构:
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
CHOU, TC
SCHOOLEY, RT
论文数:
0
引用数:
0
h-index:
0
机构:
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
SCHOOLEY, RT
HIRSCH, MS
论文数:
0
引用数:
0
h-index:
0
机构:
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
MEM SLOAN KETTERING CANC CTR,PHARMACOL LAB,NEW YORK,NY 10021
HIRSCH, MS
[J].
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,
1986,
30
(01)
: 189
-
191
←
1
2
3
→